Human prion diseases -: Molecular and clinical aspects

被引:88
作者
Glatzel, M
Stoeck, K
Seeger, H
Lührs, T
Aguzzi, A
机构
[1] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Natl Reference Ctr Prion Dis, CH-8091 Zurich, Switzerland
[3] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA USA
关键词
D O I
10.1001/archneur.62.4.545
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Compared with that of other human pathogens, the proposed replicative cycle of prions is disarmingly simple. It encompasses misfolding of a single protein, the cellular prion protein (PrPC), into a disease-associated form called PrPSc. This is followed by PrPSc aggregation and possibly fragmentation of aggregates, which may augment the number of replicative units. Although there is no formal proof of the correctness of this model, a wealth of evidence indicates that pathogen-encoded informational nucleic acids are dispensable for prion replication. Despite the simplicity of the replicative process, the human phenotypic range of prion diseases is extremely variable and includes the sporadic, inherited, and acquired forms of Creutzfeldt-Jakob disease. In addition, prion diseases occur in a wide range of animals and can be propagated within and between animal species. The present review article discusses current concepts and controversies surrounding the basic biological features of prions.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 70 条
[11]   Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease [J].
Alperovitch, A ;
Zerr, I ;
Pocchiari, M ;
Mitrova, E ;
Cuesta, JD ;
Hegyi, I ;
Collins, S ;
Kretzschmar, H ;
van Duijn, C ;
Will, RG .
LANCET, 1999, 353 (9165) :1673-1674
[12]   Diagnosis of Creutzfeldt-Jakob disease -: Effect of clinical criteria on incidence estimates [J].
Brandel, JP ;
Delasnerie-Lauprêtre, N ;
Laplanche, JL ;
Hauw, JJ ;
Alpérovitch, A .
NEUROLOGY, 2000, 54 (05) :1095-1099
[13]   Normal prion protein has an activity like that of superoxide dismutase [J].
Brown, DR ;
Wong, BS ;
Hafiz, F ;
Clive, C ;
Haswell, SJ ;
Jones, IM .
BIOCHEMICAL JOURNAL, 1999, 344 :1-5
[14]   Iatrogenic Creutzfeldt-Jakob disease at the millennium [J].
Brown, P ;
Preece, M ;
Brandel, JP ;
Sato, T ;
McShane, L ;
Zerr, I ;
Fletcher, A ;
Will, RG ;
Pocchiari, M ;
Cashman, NR ;
d'Aignaux, JH ;
Cervenáková, L ;
Fradkin, J ;
Schonberger, LB ;
Collins, SJ .
NEUROLOGY, 2000, 55 (08) :1075-1081
[15]   Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent [J].
Bruce, ME ;
Will, RG ;
Ironside, JW ;
McConnell, I ;
Drummond, D ;
Suttie, A ;
McCardle, L ;
Chree, A ;
Hope, J ;
Birkett, C ;
Cousens, S ;
Fraser, H ;
Bostock, CJ .
NATURE, 1997, 389 (6650) :498-501
[16]   NEUROPATHOLOGICAL DIAGNOSTIC-CRITERIA FOR CREUTZFELDT-JAKOB-DISEASE (CJD) AND OTHER HUMAN SPONGIFORM ENCEPHALOPATHIES (PRION DISEASES) [J].
BUDKA, H ;
AGUZZI, A ;
BROWN, P ;
BRUCHER, JM ;
BUGIANI, O ;
GULLOTTA, F ;
HALTIA, M ;
HAUW, JJ ;
IRONSIDE, JW ;
JELLINGER, K ;
KRETZSCHMAR, HA ;
LANTOS, PL ;
MASULLO, C ;
SCHLOTE, W ;
TATEISHI, J ;
WELLER, RO .
BRAIN PATHOLOGY, 1995, 5 (04) :459-466
[17]   MICE DEVOID OF PRP ARE RESISTANT TO SCRAPIE [J].
BUELER, H ;
AGUZZI, A ;
SAILER, A ;
GREINER, RA ;
AUTENRIED, P ;
AGUET, M ;
WEISSMANN, C .
CELL, 1993, 73 (07) :1339-1347
[18]   Inhibition of protease-resistant prion protein accumulation in vitro by curcumin [J].
Caughey, B ;
Raymond, LD ;
Raymond, GJ ;
Maxson, L ;
Silveira, J ;
Baron, GS .
JOURNAL OF VIROLOGY, 2003, 77 (09) :5499-5502
[19]   Transmissible spongiform encephalopathies [J].
Collins, SJ ;
Lawson, VA ;
Masters, CL .
LANCET, 2004, 363 (9402) :51-61
[20]   Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model [J].
Collins, SJ ;
Lewis, V ;
Brazier, M ;
Hill, AF ;
Fletcher, A ;
Masters, CL .
ANNALS OF NEUROLOGY, 2002, 52 (04) :503-506